Posted by Hugh on March 21, 2019, at 23:56:30
In reply to Re: FDA approves Zulresso » Hugh, posted by beckett2 on March 21, 2019, at 20:54:48
> I didn't see this post when I posted below. But I read this is given through IV for 60 hours, during which the woman must be closely monitored.
It's pretty impractical. But at least that 60-hour infusion keeps a lot of the women in remission for at least four weeks, and perhaps permanently.
SAGE-217 is taken orally once a day for two weeks, and it also puts women and men into remission for at least four weeks, and perhaps much longer.
poster:Hugh
thread:1103636
URL: http://www.dr-bob.org/babble/20190206/msgs/1103673.html